Medicare denies Alzheimer’s Affiliation’s request for protection for remedies like Leqembi

Medicare will not offer broader coverage of Alzheimer’s drug Leqembi until there is more evidence that the treatment is appropriate and necessary, according to the federal agency that runs the program for seniors. The Centers for Medicare and Medicaid Services denied an Alzheimer’s Association request for unrestricted coverage of antibody treatments approved by the Food …

West Virginia seeks to dismiss lawsuit over entry to abortion capsules

West Virginia’s Attorney General is asking a judge to dismiss a lawsuit aimed at overturning state restrictions on the abortion pill. Attorney General Patrick Morrisey on Tuesday asked federal court in the Southern District of West Virginia to dismiss the lawsuit brought by GenBioPro, which manufactures the generic version of the abortion pill called mifepristone. …

Pfizer RSV vaccine for infants might get FDA approval this summer time

David Paul Morris | Bloomberg | Getty Images PfizerThe vaccine, which protects infants from respiratory diseases, could receive Food and Drug Administration approval by the end of this summer. Pfizer said Tuesday the FDA is expediting review of the vaccine. The agency is expected to make a decision on whether to delete the shot in …

Moderna CEO Bancel is ready to testify earlier than the Senate on the Covid vaccine worth hike

Modern CEO Stéphane Bancel is due to testify before the Senate Health Committee in March about the company’s price for its Covid-19 vaccine if the shots are sold on the private market. Senator Bernie Sanders, chair of the health panel, confirmed in a statement Wednesday that Bancel would appear at a hearing titled, “Taxpayers paid …

The maker of Alzheimer’s drug Leqembi expects full FDA approval this summer time

Tek Image/Science Photo Library | Science Photo Library | Getty Images Japanese drugmaker Eisai expects the Food and Drug Administration to fully approve its Alzheimer’s treatment Leqembi this summer, which would expand access to the expensive new antibody under Medicare. US CEO Ivan Cheung said the FDA, which granted accelerated approval in January, could grant …

Senators are asking Medicare to cowl Alzheimer’s therapies

U.S. senators Friday called for Medicare to offer broad coverage of Alzheimer’s treatments approved by the Food and Drug Administration, warning that the current restrictions are costing patients valuable time as their disease progresses. “Given the progressive nature of this terminal disease, we encourage you to take action now to ensure patients have immediate access …

Synchronously assisted by Bezos and Gates exams brain-computer interface

Philip O’Keefe, one of Synchron’s patients in the SWITCH clinical trial, with his BCI. Source: Synchronous In a Brooklyn lab crammed with 3D printers and a makeshift pickleball rig, employees at a brain-interface startup called Synchron are working on technology that promises to transform the daily lives of people living with paralysis. The Synchron Switch …

Fetterman has to remain within the hospital for weeks due to melancholy

US Senator John Fetterman (D-PA) leaves a secret briefing for US senators on the latest unidentified objects shot down by the US military on Capitol Hill in Washington, United States, February 14, 2023. Evelyn Hockstein Reuters Sen. John Fetterman, D-Pa., will be hospitalized for a few weeks as he seeks treatment for his clinical depression, …

Eli Lilly recruits black sufferers for Alzheimer’s examine, drugmakers try for range

Sharon Kimbrough went to Atlanta’s Black Women’s Expo to sell her memoir. Getting tested for Alzheimer’s was the furthest thing on her mind, but off as nurses Eli Lilli When she approached her about the company’s new process, she decided to have blood drawn. “I had two family members who had Alzheimer’s,” said Kimbrough, a …

Opioid overdose therapy Narcan is really helpful by FDA advisors for over-the-counter use

The independent advisors to the Food and Drug Administration on Wednesday unanimously recommended over-the-counter use of the nasal spray Narcan to reverse opioid overdoses, which would greatly expand access to the life-saving treatment. Emerging biosolutions‘ Narcan is the top-selling treatment for opioid overdoses. The FDA is expected to make a decision by March 29 on …